 | Related Articles |
Bezlotoxumab (Zinplava) for Clostridium Difficile Infection: The First Monoclonal Antibody Approved to Prevent the Recurrence of a Bacterial Infection.
P T. 2017 Dec;42(12):735-738
Authors: Lee Y, Lim WI, Bloom CI, Moore S, Chung E, Marzella N
Abstract
Bezlotoxumab (Zinplava) to prevent the recurrence of Clostridium difficile infection.
PMID: 29234211 [PubMed]